Multimodality Imaging in Endomyocardial Fibrosis: An Unusual Etiology of Heart Failure.
Ontology highlight
ABSTRACT:
SUBMITTER: Velandia-Carrillo C
PROVIDER: S-EPMC8551396 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
Publications
Multimodality Imaging in Endomyocardial Fibrosis: An Unusual Etiology of Heart Failure.
Velandia-Carrillo Carlos C Zuluaga Jose F JF
CASE (Philadelphia, Pa.) 20210708 5
Similar Datasets
Project description:BackgroundEndomyocardial fibrosis (EMF) is a rare restrictive heart disease of the tropics. Its aetiology is cryptogenic; however, some hypotheses have been described. The clinical course is characterized by the presence of three phases (acute, subacute, and chronic). Most of the typical features of the disease are identified in the chronic phase. Multimodality imaging allows a presumptive diagnosis and cardiac magnetic resonance imaging, through its tissue characterization, allows confirmation of the diagnosis.Case summaryWe present three clinical cases of patients with EMF, at different stages of the disease, which constituted a diagnostic challenge. However, it is due to multimodality imaging that a timely and accurate diagnosis is achieved.DiscussionEndomyocardial fibrosis is a rare heart disease with a restrictive phenotype and a poor prognosis. Endomyocardial fibrosis is characterized by apical obliteration with fibrous tissue, of one or both ventricles, and is usually associated with thrombosis, calcification, and AV valve insufficiency. Transthoracic echocardiogram is the first-line imaging modality to assess for EMF. Cardiac magnetic resonance, through late gadolinium enhancement, allows tissue characterization and identifies the 'double V sign', which is pathognomonic of the disease, allowing confirmation of the diagnosis. Therefore, multimodality imaging is essential for the initial and definitive diagnosis of this disease.
| S-EPMC11833696 | biostudies-literature
Project description:Rheumatic heart disease (RHD) and endomyocardial fibrosis (EMF) are major causes of cardiac disease in low-income countries. We present a case of a patient with mitral stenosis and restrictive cardiomyopathy, initially attributed to severe RHD, but with disease progression despite valve replacement, likely secondary to previously undiagnosed EMF.
| S-EPMC11646894 | biostudies-literature
Project description:Heart failure secondary to isolated pulmonary artery vasculitis is rarely described in children. We describe a 10-year-old child who presented with right heart failure symptoms, severe pulmonary hypertension, and bilateral branch pulmonary artery stenosis secondary to isolated pulmonary artery vasculitis. (Level of Difficulty: Advanced.).
| S-EPMC8642737 | biostudies-literature
Project description:A previously healthy 31-year-old man presented with worsening shortness of breath and a petechial rash. Echocardiography showed severe right-sided heart failure with midsystolic notching of the antegrade right ventricular outflow Doppler envelope suggesting pulmonary hypertension. An extensive work-up revealed scurvy, with a dramatic resolution of symptoms shortly after vitamin C supplementation.
| S-EPMC10920146 | biostudies-literature
Project description:BackgroundIntracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance very different from that usually seen. Fresh thrombosis has been previously found also in peripartum cardiomyopathy (PPC), but with imaging features different from our case.Case summaryA 27-year-old woman was referred to our hospital for PPC, with echocardiographic finding of intraventricular masses, resembling big bubbles. Cardiac magnetic resonance (CMR) allowed definitively diagnosing intracardiac 'very acute' thrombosis, which is rarely detected.DiscussionOur case provides a practical lesson about management of an unusual presentation of a common problem. When early echocardiography does not allow making a certain diagnosis, CMR can be helpful and decisive, due to its unique ability to provide characterization of intracardiac masses.
| S-EPMC7873811 | biostudies-literature
Project description:Inflammation contributes to ventricular remodeling after myocardial ischemia, but its role in nonischemic heart failure is poorly understood. Local tissue inflammation is difficult to assess serially during pathogenesis. Although 18F-FDG accumulates in inflammatory leukocytes and thus may identify inflammation in the myocardial microenvironment, it remains unclear whether this imaging technique can isolate diffuse leukocytes in pressure-overload heart failure. We aimed to evaluate whether inflammation with 18F-FDG can be serially imaged in the early stages of pressure-overload-induced heart failure and to compare the time course with functional impairment assessed by cardiac MRI. Methods: C57Bl6/N mice underwent transverse aortic constriction (TAC) (n = 22), sham surgery (n = 12), or coronary ligation as an inflammation-positive control (n = 5). MRI assessed ventricular geometry and contractile function at 2 and 8 d after TAC. Immunostaining identified the extent of inflammatory leukocyte infiltration early in pressure overload. 18F-FDG PET scans were acquired at 3 and 7 d after TAC, under ketamine-xylazine anesthesia to suppress cardiomyocyte glucose uptake. Results: Pressure overload evoked rapid left ventricular dilation compared with sham (end-systolic volume, day 2: 40.6 ± 10.2 μL vs. 23.8 ± 1.7 μL, P < 0.001). Contractile function was similarly impaired (ejection fraction, day 2: 40.9% ± 9.7% vs. 59.2% ± 4.4%, P < 0.001). The severity of contractile impairment was proportional to histology-defined myocardial macrophage density on day 8 (r = -0.669, P = 0.010). PET imaging identified significantly higher left ventricular 18F-FDG accumulation in TAC mice than in sham mice on day 3 (10.5 ± 4.1 percentage injected dose [%ID]/g vs. 3.8 ± 0.9 %ID/g, P < 0.001) and on day 7 (7.8 ± 3.7 %ID/g vs. 3.0 ± 0.8 %ID/g, P = 0.006), though the efficiency of cardiomyocyte suppression was variable among TAC mice. The 18F-FDG signal correlated with ejection fraction (r = -0.75, P = 0.01) and ventricular volume (r = 0.75, P < 0.01). Western immunoblotting demonstrated a 60% elevation of myocardial glucose transporter 4 expression in the left ventricle at 8 d after TAC, indicating altered glucose metabolism. Conclusion: TAC induces rapid changes in left ventricular geometry and contractile function, with a parallel modest infiltration of inflammatory macrophages. Metabolic remodeling overshadows inflammatory leukocyte signal using 18F-FDG PET imaging. More selective inflammatory tracers are requisite to identify the diffuse local inflammation in pressure overload.
| S-EPMC7198376 | biostudies-literature
Project description:Tropical endomyocardial fibrosis is a common cause of restrictive cardiomyopathy worldwide, but is relatively rare in developed countries. We present a case of tropical endomyocardial fibrosis with right ventricular involvement initially mistaken as Ebstein's anomaly. We highlight the need for timely and accurate diagnosis to ensure appropriate management. (Level of Difficulty: Intermediate.).
| S-EPMC8301721 | biostudies-literature
Project description:The increasing number of survivors of congenital heart disease (CHD) has been paralleled by advancement of imaging modalities used for the ongoing assessment of these patients. There has been a large body of literature describing new approaches to non-invasive assessment of CHD. We will review new applications of well established as well as novel techniques for the management and understanding of CHD.
| S-EPMC4032470 | biostudies-literature
Project description: Not available
| S-EPMC6710901 | biostudies-literature
Project description:Peripartum cardiomyopathy is a weakness of the heart muscle. It is an idiopathic cardiomyopathy that presents with heart failure secondary to left ventricular systolic dysfunction toward the end of pregnancy or in the months after delivery, in the absence of any other cause of heart failure. It is a rare condition that can carry mild or severe symptoms.
| S-EPMC5290678 | biostudies-literature